Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (321-330 of 457) with videos related to

Pageof 46
Sort By:
Haematologica|February 1, 2024
Genetic landscape and clinical outcomes of patients with <i>BCOR</i> mutated myeloid neoplasmsAnmol Baranwal, Mark Gurney, Rami Basmaci, et al.
Acta Haematologica|September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic LeukemiaMuhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remissionDavid I Marks, Stephen J Forman, Karl G Blume, et al.
Blood Advances|August 21, 2024
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemiaBetty K Hamilton, Bhavik J Pandya, Cristina Ivanescu, et al.
Leukemia & Lymphoma|April 9, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Razan Mohty, Ravi Narra, Alice S Mims, et al.
Leukemia Research|May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic TrialsStephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Blood|December 16, 2006
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V Moorman, Christine J Harrison, Georgina A N Buck, et al.
Blood Neoplasia|April 30, 2026
Outcomes of hemophagocytic lymphohistiocytosis in acute myeloid leukemia: the 3-site Mayo Clinic experienceJabra Zarka, Clifford M Csizmar, Syeda Mina, et al.
American Journal of Hematology|March 6, 2025
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk CriteriaAldo A Acosta-Medina, Meera Sridharan, Ronald S Go, et al.
Pageof 46

Showing results (321-330 of 457) with videos related to

Sort By:
Pageof 46
Haematologica|February 1, 2024
Genetic landscape and clinical outcomes of patients with <i>BCOR</i> mutated myeloid neoplasmsAnmol Baranwal, Mark Gurney, Rami Basmaci, et al.
Acta Haematologica|September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic LeukemiaMuhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 29, 2008
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathyMartha Q Lacy, Angela Dispenzieri, Suzanne R Hayman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remissionDavid I Marks, Stephen J Forman, Karl G Blume, et al.
Blood Advances|August 21, 2024
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemiaBetty K Hamilton, Bhavik J Pandya, Cristina Ivanescu, et al.
Leukemia & Lymphoma|April 9, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Razan Mohty, Ravi Narra, Alice S Mims, et al.
Leukemia Research|May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic TrialsStephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Blood|December 16, 2006
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V Moorman, Christine J Harrison, Georgina A N Buck, et al.
Blood Neoplasia|April 30, 2026
Outcomes of hemophagocytic lymphohistiocytosis in acute myeloid leukemia: the 3-site Mayo Clinic experienceJabra Zarka, Clifford M Csizmar, Syeda Mina, et al.
American Journal of Hematology|March 6, 2025
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk CriteriaAldo A Acosta-Medina, Meera Sridharan, Ronald S Go, et al.
Pageof 46